+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients

Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients

Indian Journal of Surgery 69(5): 187-190

The art of administering immunosuppression lies in the ability to achieve a delicate balance between rejection and infection, thus maximizing patient survival and minimizing morbidity. To analyze the effect of immunosuppression strategies following liver transplant on the incidence of acute rejection, bile leak, renal dysfunction and posttransplant graft unrelated infection. A retrospective analysis of immunosuppression regimens in 57 liver transplant recipients between Jan 1998 to July 2004 at a single institution. For the purpose of study, the patients were divided into two groups: A - Cyclosporine based therapy (n=37), and B - Tacrolimus based therapy (n=20). In addition, both groups received Azathioprine or Mycophenolate mofetil with steroids. There were two subgroups in each Group A and B: Group C - Received induction using IL2Rab (n=5), and D - Where Sirolimus was used instead of Mycophenolate mofetil (N=7). The subgroups were equally distributed among the basic groups. The regimen was started based on one of the standard protocols but changes were made according to the clinical status of each patient. The statistical analysis was done using Chi square test on SPSS12. A lower incidence of rejection was observed in Tacrolimus group compared to Cyclosporine group. There was an unacceptably high incidence of bile leak in patients where Sirolimus was used as an adjunct. IL2Rab enabled us to maintain a lower trough level of Tacrolimus for maintenance and enabled us to discontinue steroids earlier. Based on this study we dropped Sirolimus from our immunosuppression protocol and the encouraging results obtained with tacrolimus based therapy have supported its use as standard therapy in our immunosuppression regimens.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053707598

Download citation: RISBibTeXText

PMID: 23132979

DOI: 10.1007/s12262-007-0018-0

Related references

Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience. Hepatology International 8(1): 137-145, 2014

The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experience. Romanian Journal of Anaesthesia and Intensive Care 23(1): 19-26, 2016

Strategies for optimizing immunosuppression in adolescent transplant recipients: a focus on liver transplantation. Paediatric Drugs 5(3): 177-183, 2003

Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations. Canadian Journal of Gastroenterology and Hepatology 29(8): 417-422, 2016

Immunosuppression with low-dose daclizumab in liver transplant recipients with impaired kidney function: a single-center experience. Transplantation Proceedings 41(8): 3107-3109, 2010

Surgical morbidity in severely obese liver transplant recipients - a single Canadian Centre Experience. Annals of Hepatology 8(1): 38-40, 2009

Biliary cast syndrome: literature review and a single centre experience in liver transplant recipients. Hepatobiliary and Pancreatic Diseases International 7(3): 300-303, 2008

Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre. Indian Journal of Medical Microbiology 35(4): 499-503, 2018

Anaesthesia and intensive care for simultaneous liver-kidney transplantation: A single-centre experience with 12 recipients. Indian Journal of Anaesthesia 60(7): 476-483, 2016

Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre. Memorias do Instituto Oswaldo Cruz 106(3): 339-345, 2011

Increased morbidity in overweight and obese liver transplant recipients A single centre experience of 1325 patients from the United Kingdom. 2013

A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety. Transplantation Proceedings 33(7-8): 3439-3441, 2001

Cardiac work-up protocol for liver transplant candidates: experience from a single liver transplant centre. Canadian Journal of Gastroenterology 26(11): 806-810, 2013

Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center. Transplantation Proceedings 37(2): 1119-1121, 2005

Paediatric orthotopic liver transplantation: lessons from a 532 transplant single centre experience with 532 transplants in 446 children. Acta Gastro-Enterologica Belgica 62(3): 290-294, 1999